Santiago, Chile

Luis O Burzio Eriz

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Luis O Burzio Eriz: Innovator in Cancer Treatment

Introduction

Luis O Burzio Eriz is a prominent inventor based in Santiago, Chile. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for cancer. With a total of 4 patents to his name, Burzio Eriz is recognized for his groundbreaking work in the medical field.

Latest Patents

One of his latest patents focuses on antisense oligonucleotides for the treatment of cancer stem cells. This invention provides oligonucleotides that are complementary to a non-coding chimeric mitochondrial RNA. It also includes compositions and kits that utilize these oligonucleotides for treating and preventing metastasis or relapse of cancer in individuals who have previously undergone cancer therapy. Additionally, the invention addresses the treatment of refractory cancers, such as those associated with HPV.

Career Highlights

Throughout his career, Burzio Eriz has worked with notable companies in the biotechnology sector, including Andes Biotechnologies Global, Inc. and Andes Biotechnologies S.A. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Some of his notable coworkers include Veronica A Burzio Menendez and Jaime E Villegas Olavarria. Their collaborative efforts have contributed to the success of various projects in the field of biotechnology.

Conclusion

Luis O Burzio Eriz is a distinguished inventor whose work in cancer treatment has the potential to change lives. His innovative patents and collaborations highlight his commitment to advancing medical science and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…